Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells

Israel, Mason A., Yuan, Shauna H., Bardy, Cedric, Reyna, Sol M., Mu, Yangling, Herrera, Cheryl, Hefferan, Michael P., Van Gorp, Sebastiaan +9 more·2012·Nature

DOI 10.1038/nature10821

Cited by (1,001)

Items 201–300 of 1,001

PI3K/AKT Signaling Pathway Is Essential for Survival of Induced Pluripotent Stem Cells
Amir M. Hossini, Sandra-Annika Quast, Michael Plötz, M. Katharina Grauel, Tarik Exner, Judit Küchler, Harald Stachelscheid, Jürgen Eberle, Anja Rabien, Evgenia Makrantonaki et al. · 2016 · PLoS ONE
New lessons learned from disease modeling with induced pluripotent stem cells
Tamer T. Önder, George Q. Daley · 2012 · Current Opinion in Genetics & Development
Small regulators, major consequences – Ca2+ and cholesterol at the endosome–ER interface
Rik van der Kant, Jacques Neefjes · 2014 · Journal of Cell Science
Effect of Potent γ-Secretase Modulator in Human Neurons Derived From Multiple Presenilin 1–Induced Pluripotent Stem Cell Mutant Carriers
Qing Liu, Shannon Waltz, Grace Woodruff, Joe Ouyang, Mason A. Israel, Cheryl M. Herrera, Floyd M. Sarsoza, Rudolph E. Tanzi, Edward H. Koo, John Matthew Ringman et al. · 2014 · JAMA Neurology
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Pieter Jelle Visser, Lianne Maria Reus, Johan Gobom, Iris E. Jansen, Ellen Dicks, Sven J. van der Lee, Magda Tsolaki, Frans R.J. Verhey, Julius Popp, Pablo Martínez‐Lage et al. · 2022 · Molecular Neurodegeneration
Therapeutic Translation of iPSCs for Treating Neurological Disease
Diana Xuan Yu, Maria Carolina Marchetto, Fred H. Gage · 2013 · Cell stem cell
The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease
Pedro M. Pimentel‐Coelho, Serge Rivest · 2012 · European Journal of Neuroscience
The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction
Maria Carmen Inda, Suhasini Joshi, Tai Wang, Alexander Bolaender, Srinivasa R. Gandu, John Koren, Alicia Yue, Tony Taldone, Pengrong Yan, Weilin Sun et al. · 2020 · Nature Communications
Synaptic dysfunction in early phases of Alzheimer's Disease
Silvia Pelucchi, Fabrizio Gardoni, Mónica Di Luca, Elena E. Marcello · 2022 · Handbook of clinical neurology
Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability
Christina Muratore, Constance Q. Zhou, Meichen Liao, Marty A. Fernandez, Walter M. Taylor, Valentina N. Lagomarsino, Richard V. Pearse, Heather C. Rice, Joseph M. Negri, Amy He et al. · 2017 · Stem Cell Reports
Recent Progress in Alzheimer’s Disease Research, Part 1: Pathology
Francis T. Hane, Brenda Yasie Lee, Zoya Leonenko · 2017 · Journal of Alzheimer s Disease
Functional Maturation of Human Stem Cell-Derived Neurons in Long-Term Cultures
Rebecca S. Lam, Felix M. Töpfer, Phillip G. Wood, Volker Busskamp, Ernst Bamberg · 2017 · PLoS ONE
Drug Repositioning Approaches for the Discovery of New Therapeutics for Alzheimer's Disease
Taewan Kim · 2014 · Neurotherapeutics
Induced pluripotent stem cells in Alzheimer’s disease: applications for disease modeling and cell-replacement therapy
Juan Yang, Song Li, Xi‐Biao He, Cheng Cheng, Weidong Le · 2016 · Molecular Neurodegeneration
Human pluripotent stem cell–derived models and drug screening in CNS precision medicine
M. Catarina Silva, Stephen J. Haggarty · 2019 · Annals of the New York Academy of Sciences
Establishment of Induced Pluripotent Stem Cells from Centenarians for Neurodegenerative Disease Research
Takuya Yagi, Arifumi Kosakai, Daisuke Ito, Yohei Okada, Wado Akamatsu, Yoshihiro Nihei, Akira Nabetani, Fuyuki Ishikawa, Yasumichi Arai, Nobuyoshi Hirose et al. · 2012 · PLoS ONE
Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases
Kelly M. Haston, Steven M. Finkbeiner · 2015 · The Annual Review of Pharmacology and Toxicology
Characteristic analyses of a neural differentiation model from iPSC-derived neuron according to morphology, physiology, and global gene expression pattern
Sai Kang, Xiaoxia Chen, Siyi Gong, Panpan Yu, SukYu Yau, Zhenghui Su, Libing Zhou, Jiandong Yu, Guangjin Pan, Lingling Shi · 2017 · Scientific Reports
Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review
Erwin Lemche · 2018 · Current Genomics
Extracellular Forms of Aβ and Tau from iPSC Models of Alzheimer’s Disease Disrupt Synaptic Plasticity
Neng‐Wei Hu, Grant T. Corbett, Steven Moore, Igor V. Klyubin, Tiernan T. O’Malley, Dominic M. Walsh, Frederick J. Livesey, Michael J. Rowan · 2018 · Cell Reports
Forced cell cycle exit and modulation of GABAA, CREB, and GSK3β signaling promote functional maturation of induced pluripotent stem cell-derived neurons
Vsevolod Telezhkin, Christian Schnell, Polina Yarova, Sun Yung, Emma L. Cope, Alis Hughes, Belinda A.N. Thompson, Phil Sanders, Charlene Smith-Geater, Jane M. Hancock et al. · 2015 · American Journal of Physiology-Cell Physiology
Vps10 Family Proteins and the Retromer Complex in Aging-Related Neurodegeneration and Diabetes
Rachel F. Lane, Peter St George‐Hyslop, Barbara L. Hempstead, Scott A. Small, Stephen M. Strittmatter, Sam Gandy · 2012 · Journal of Neuroscience
Culture Variabilities of Human iPSC-Derived Cerebral Organoids Are a Major Issue for the Modelling of Phenotypes Observed in Alzheimer’s Disease
Damián Hernández, Louise A. Rooney, Maciej Daniszewski, Lerna M. Gulluyan, Helena Hai Liang, Anthony L. Cook, Alex William Hewitt, Alice Pébay · 2021 · Stem Cell Reviews and Reports
A Multistep Workflow to Evaluate Newly Generated iPSCs and Their Ability to Generate Different Cell Types
Carol X.‐Q. Chen, Narges Abdian, Gilles Maussion, Rhalena A. Thomas, Iveta Demirova, Eddie Cai, Mahdieh Tabatabaei, Lenore K. Beitel, Jason Karamchandani, Edward A. Fon et al. · 2021 · Methods and Protocols
Modeling Neurodegenerative Microenvironment Using Cortical Organoids Derived from Human Stem Cells
Yuanwei Yan, Liqing Song, Julie Bejoy, Jing Zhao, Takahisa Kanekiyo, Guojun Bu, Yi Zhou, Yan Li · 2018 · Tissue Engineering Part A
Exposure to phthalates impaired neurodevelopment through estrogenic effects and induced DNA damage in neurons
Shisan Xu, Huan Zhang, Ping‐Chieh Pao, Audrey Lee, Jun Wang, Yu Suen Chan, Francis A. M. Manno, Shun‐Wan Chan, Shuk Han Cheng, Xueping Chen · 2020 · Aquatic Toxicology
NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models
Swagata Ghatak, Nima Dolatabadi, Richard Gao, Yin Wu, Henry R. Scott, Dorit Trudler, Abdullah Sultan, Rajesh Ambasudhan, Tomohiro Nakamura, Eliezer Masliah et al. · 2020 · Molecular Psychiatry
N-butylidenephthalide Attenuates Alzheimer's Disease-Like Cytopathy in Down Syndrome Induced Pluripotent Stem Cell-Derived Neurons
Chia‐Yu Chang, Sheng-Mei Chen, Huai-En Lu, Syu-Ming Lai, Ping‐Shan Lai, Po-Wen Shen, Pei-Ying Chen, Ching-I Shen, Horng‐Jyh Harn, Shinn‐Zong Lin et al. · 2015 · Scientific Reports
Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities
Francesca Pistollato, Elan Liss Ohayon, Ann Lam, Gillian R. Langley, Thomas J. Novak, David Pamies, George L. Perry, Eugenia V. Trushina, Robin S. B. Williams, Alex E. Roher et al. · 2016 · Oncotarget
Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming
Sun, Zhao, Kwon, Ji-Sun, Ren, Yudong, Chen, Shawei, Walker, Courtney K., Lu, Xinguo, Cates, Kitra, Karahan, Hande, Sviben, Sanja, Fitzpatrick, James A. J. et al. · 2024 · Science
“Seq-ing” Insights into the Epigenetics of Neuronal Gene Regulation
Francesca Telese, Amir Gamliel, Dorota Skowronska‐Krawczyk, Ivan García-Bassets, Michael G. Rosenfeld · 2013 · Neuron
Experimental models of Alzheimer's disease for deciphering the pathogenesis and therapeutic screening (Review)
Xueyuan Li, Xinjie Bao, Renzhi Wang · 2015 · International Journal of Molecular Medicine
High-Throughput and Cost-Effective Characterization of Induced Pluripotent Stem Cells
Matteo D’Antonio, Grace Woodruff, Jason L. Nathanson, Agnieszka D’Antonio‐Chronowska, Angelo D. Arias, Hiroko Matsui, Roy M. Williams, Cheryl M. Herrera, Sol M. Reyna, Gene Wei-Ming Yeo et al. · 2017 · Stem Cell Reports
Neuronal Exosome-Derived Human Tau is Toxic to Recipient Mouse Neurons in vivo
Charisse N. Winston, Brent D. Aulston, Edward M. Rockenstein, Anthony Adame, Olga Prikhodko, Kishan N. Dave, Priyanka Mishra, Robert A. Rissman, Shauna H. Yuan · 2018 · Journal of Alzheimer s Disease
Brain organoids: a next step for humanized Alzheimer’s disease models?
Yannis Gerakis, Claudio A. Hetz · 2019 · Molecular Psychiatry
Disruption of endoplasmic reticulum-mitochondria tethering proteins in post-mortem Alzheimer's disease brain
Dawn H. W. Lau, Sébastien Paillusson, Naomi Hartopp, Huzefa Rupawala, Gábor M. Mórotz, Patricia Gómez‐Suaga, Jenny Greig, Claire Troakes, Wendy J. Noble, Christopher C.J. Miller · 2020 · Neurobiology of Disease
Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy
Subrata Pramanik, Yanuar Alan Sulistio, Klaus Heese · 2016 · Molecular Neurobiology
AMPA Receptor Trafficking in Natural and Pathological Aging
Sandra Jurado · 2018 · Frontiers in Molecular Neuroscience
Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease
Yi‐Ying Wu, Feng‐Lan Chiu, Chan-Shien Yeh, Hung‐Chih Kuo · 2019 · Open Biology
Modeling Parkinson’s Disease Using Induced Pluripotent Stem Cells
Blake Byers, Hsiao‐lu D. Lee, Renee A. Reijo Pera · 2012 · Current Neurology and Neuroscience Reports
Disruption of ER−mitochondria signalling in fronto-temporal dementia and related amyotrophic lateral sclerosis
Dawn H. W. Lau, Naomi Hartopp, Natalie J. Welsh, Sarah Mueller, Elizabeth B. C. Glennon, Gábor M. Mórotz, Ambra Annibali, Patricia Gómez‐Suaga, Radu Stoica, Sébastien Paillusson et al. · 2018 · Cell Death and Disease
Animal Models of Neurodegenerative Disease: Recent Advances in Fly Highlight Innovative Approaches to Drug Discovery
Judith A. Tello, Haley Williams, Robert Eppler, Michelle Leigh Steinhilb, May Khanna · 2022 · Frontiers in Molecular Neuroscience
Low-Level Light in Combination with Metabolic Modulators for Effective Therapy of Injured Brain
Tingting Dong, Qi Zhang, Michael Richard Hamblin, Mei X. Wu · 2015 · Journal of Cerebral Blood Flow & Metabolism
Telomerase reverse transcriptase preserves neuron survival and cognition in Alzheimer’s disease models
Shim, Hong Seok, Horner, James W., Wu, Chang-Jiun, Li, Jiexi, Lan, Zheng D., Jiang, Shan, Xu, Xueping, Hsu, Wen-Hao, Zal, Tomasz, Flores, Ivonne I. et al. · 2021 · Nature Aging
Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-β clearance in human astrocytes
Lauren K. Fong, Max M. Yang, Rodrigo dos Santos Chaves, Sol M. Reyna, Vanessa F. Langness, Grace Woodruff, Elizabeth A. Roberts, Jessica E. Young, Lawrence S.B. Goldstein · 2018 · Journal of Biological Chemistry
The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders
Margrethe A. Olesen, Francisca Villavicencio-Tejo, R. Quintanilla · 2022 · Translational Neurodegeneration
Regulation of neuronal autophagy and the implications in neurodegenerative diseases
Qian Cai, Dhasarathan Ganesan · 2021 · Neurobiology of Disease
Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer’s disease
Aman P. Mann, Pablo Scodeller, Sazid Hussain, Gary B. Braun, Tarmo Mölder, Kadri Toome, Rajesh Ambasudhan, Tambet Teesalu, Stuart A. Lipton, Erkki I. Ruoslahti · 2017 · Nature Communications
Dedifferentiation and neuronal repression define familial Alzheimer’s disease
Caldwell, Andrew B., Liu, Qing, Schroth, Gary P., Galasko, Douglas R., Yuan, Shauna H., Wagner, Steven L., Subramaniam, Shankar · 2020 · Science Advances
Induced pluripotent stem (iPS) cells: A new source for cell-based therapeutics?
Irene de Lázaro, Açelya Yılmazer, Kostas Kostarelos · 2014 · Journal of Controlled Release
Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe application
Changsung Kim · 2014 · Blood Research
Towards Advanced iPSC-based Drug Development for Neurodegenerative Disease
Svetlana Pasteuning-Vuhman, Rianne de Jongh, Annabel Timmers, R. Jeroen Pasterkamp · 2020 · Trends in Molecular Medicine
iPSC technology to study human aging and aging-related disorders
Guang‐Hui Liu, Zhichao Ding, Juan Carlos Izpisúa Belmonte · 2012 · Current Opinion in Cell Biology
Modeling Human Neurological and Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Neuronal Differentiation and Its Applications in Neurotrauma
Hisham F. Bahmad, Ola Hadadeh, Farah Chamaa, Katia Anis Cheaito, Batoul Darwish, Ahmad-Kareem Makkawi, Wassim G. Abou-Kheir · 2017 · Frontiers in Molecular Neuroscience
The Role of P2X7 Receptor in Alzheimer’s Disease
Linda Francistiová, Carolina Bianchi, Caterina Di Lauro, Álvaro Sebastián‐Serrano, Laura de Diego-García, Julianna Kobolák, András Dinnyés, Miguel Dı́az-Hernández · 2020 · Frontiers in Molecular Neuroscience
Coordinated Messenger RNA/MicroRNA Changes in Fibroblasts of Patients with Major Depression
Krassimira A. Garbett, Andrea Vereczkei, Sára Kálmán, Jacquelyn Ann Brown, Warren D. Taylor, Gábor Faludi, Željka Korade, Richard Charles Shelton, Károly Mirnics · 2014 · Biological Psychiatry
G-quadruplexes originating from evolutionary conserved L1 elements interfere with neuronal gene expression in Alzheimer’s disease
Roy Hanna, Anthony Flamier, Andrea Barabino, Gilbert Bernier · 2021 · Nature Communications
Recent advances in the applications of iPSC technology
Connor Wiegand, Ipsita Banerjee · 2019 · Current Opinion in Biotechnology
Phospholipase D3 degrades mitochondrial DNA to regulate nucleotide signaling and APP metabolism
Zoë P. Van Acker, Anika Perdok, Ruben Hellemans, Katherine North, Inge Vorsters, Cedric Curt Cappel, Jonas Dehairs, Johannes V. Swinnen, Ragna Sannerud, Marine Bretou et al. · 2023 · Nature Communications
Modeling Late-Onset Sporadic Alzheimer’s Disease through BMI1 Deficiency
Anthony Flamier, Jida El Hajjar, James Adjaye, Karl J. L. Fernandes, Mohamed Abdouh, Gilbert Bernier · 2018 · Cell Reports
Dissecting the complexities of Alzheimer disease with in vitro models of the human brain
Joel Blanchard, Matheus B. Victor, Li‐Huei Tsai · 2021 · Nature Reviews Neurology
Axonal transport and neurodegenerative disease: Can we see the elephant?
Lawrence S.B. Goldstein · 2012 · Progress in Neurobiology
Common pitfalls of stem cell differentiation: a guide to improving protocols for neurodegenerative disease models and research
Martin Engel, Dzung Do‐Ha, Sonia Sanz Muñoz, Lezanne Ooi · 2016 · Cellular and Molecular Life Sciences
Stem‐Cell Challenges in the Treatment of Alzheimer's Disease: A Long Way from Bench to Bedside
Xiaotang Fan, Dayu Sun, Xiaotong Tang, Yulong Cai, Zheng Qin Yin, Haiwei Xu · 2014 · Medicinal Research Reviews
Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells
Xiaohong Xu, Zhong Zhong · 2013 · Acta Pharmacologica Sinica
What is the point of large-scale collections of human induced pluripotent stem cells?
Ruth M. McKernan, Fiona M. Watt · 2013 · Nature Biotechnology
Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling.
S. Hirata, Naoya Takayama, Ryoko Jono-Ohnishi, H. Endo, Sou Nakamura, Takeaki Dohda, Masanori Nishi, Yuhei Hamazaki, E. Ishii, S. Kaneko et al. · 2013 · Journal of Clinical Investigation
Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer’s Disease
Philip W. Brownjohn, James C. Smith, Erik Portelius, Lutgarde Serneels, Hlin Kvartsberg, Bart De Strooper, Kaj Blennow, Henrik Zetterberg, Frederick J. Livesey · 2017 · Stem Cell Reports
The Alzheimer susceptibility gene BIN1 induces isoform-dependent neurotoxicity through early endosome defects
Erwan Lambert, Orthis Saha, Bruna Soares Landeira, Ana Raquel Melo de Farias, Xavier Hermant, Arnaud Carrier, Alexandre Pelletier, Johanna Gadaut, Lindsay Davoine, Cloé Dupont et al. · 2022 · Acta Neuropathologica Communications
Multivesicular bodies mediate long-range retrograde NGF-TrkA signaling
Mengchen Ye, Kathryn M. Lehigh, David D. Ginty · 2018 · eLife
Dynamic Characterization of Structural, Molecular, and Electrophysiological Phenotypes of Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoids, and Comparison with Fetal and Adult Gene Profiles
Sarah Logan, Thiago Arzua, Yasheng Yan, Congshan Jiang, Xiaojie Liu, Laikang Yu, Qing-song Liu, Xiaowen Bai · 2020 · Cells
Alzheimer’s disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery
Yanru Ji, Xiaoling Chen, Zhen Wang, Connor Joseph Meek, Jenna Lillie McLean, Yang Yang, Chongli Yuan, Jean‐Christophe Rochet, Fei Liu, Ranjie Xu · 2025 · Molecular Psychiatry
A practical guide to induced pluripotent stem cell research using patient samples
Katherine E. Santostefano, Takashi Hamazaki, Nikolett M. Biel, Shouguang Jin, Akihiro Umezawa, Naohiro Terada · 2014 · Laboratory Investigation
Epigenetic regulation of adult neural stem cells: implications for Alzheimer’s disease
Carlos Patricio Fitzsimons, Emma J. van Bodegraven, Marijn Schouten, Roy Lardenoije, Konstantinos Kompotis, Günter Kenis, Mark van den Hurk, Marco P. Boks, Caroline Biojone, Sâmia R.L. Joca et al. · 2014 · Molecular Neurodegeneration
Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
Sanjib Guha, Sarah Fischer, G. Johnson, K. Nehrke · 2020 · Molecular Neurodegeneration
Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer’s disease (PSEN1-A246E) induced pluripotent stem cells
Enrique Armijo, César González, Mohammad Shahnawaz, Andrea Flores, Brian R. Davis, Claudio A. Soto · 2016 · Neuroscience Letters
Recent Expansions on Cellular Models to Uncover the Scientific Barriers Towards Drug Development for Alzheimer’s Disease
Sunil Kumar Dubey, Siva Ram Munnangi, Kowthavarapu Venkata Krishna, Ranendra Narayan Saha, Gautam Singhvi, Mukta Agrawal, M. Ajazuddin, Swarnlata Saraf, Shailendra Saraf, Amit Alexander · 2019 · Cellular and Molecular Neurobiology
The future of stem cell therapies of Alzheimer’s disease
Zhibo Wang, Zuo-Teng Wang, Yan Sun, Lan Tan, Jin‐Tai Yu · 2022 · Ageing Research Reviews
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells
Wenliang Li, Li Ting Huang, Jinsheng Zeng, Wen‐chang Lin, K Li, J Sun, Weijun Huang, J Chen, Guo‐Cai Wang, Qiong Ke et al. · 2016 · Molecular Psychiatry
Neuroprotective potential of astroglia
Beihui Liu, Anja G. Teschemacher, Sergey Kasparov · 2017 · Journal of Neuroscience Research
Application of Stem Cells in Stroke: A Multifactorial Approach
Manisha Singh, Pranav K. Pandey, Ashu Bhasin, M. V. Padma, Sujata Mohanty · 2020 · Frontiers in Neuroscience
The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells
Wenjun Cai, Tong Wu, Ning Chen · 2023 · Biomolecules
Capillarity Enabled Large‐Array Liquid Metal Electrodes for Compact and High‐Throughput Dielectrophoretic Microfluidics
Huichao Chai, Junwen Zhu, Yongxiang Feng, Fei Liang, Qiyan Wu, Zhongjian Ju, Liang Jun Huang, Wenhui Wang · 2024 · Advanced Materials
Modeling Alzheimer’s disease: from past to future
Claudia Saraceno, Stefano Musardo, Elena E. Marcello, Silvia Pelucchi, Mónica Di Luca · 2013 · Frontiers in Pharmacology
Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation
Patrick Reilly, Charisse N. Winston, Kelsey R Baron, Margarita Trejo, Edward M. Rockenstein, Johnny C. Akers, Najla Kfoury, Marc I. Diamond, Eliezer Masliah, Robert A. Rissman et al. · 2017 · Neurobiology of Disease
Prospects for the application of mesenchymal stem cells in Alzheimer's disease treatment
Forough Chakari-Khiavi, Sanam Dolati, Aref Chakari-Khiavi, Hossein Abbaszadeh, Leili Aghebati Maleki, Tannaz Pourlak, Amir Mehdizadeh, Mehdi Yousefi · 2019 · Life Sciences
Decoding the non-coding RNAs in Alzheimer’s disease
Nicole Schönrock, Jürgen Götz · 2012 · Cellular and Molecular Life Sciences
Neuron–astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation
Kakulavarapu V. Rama Rao, Tammy Kielian · 2015 · Clinical and Experimental Neuroimmunology
iPS cell derived neuronal cells for drug discovery
Ralf Heilker, Stefanie Traub, Peter Reinhardt, Hans Robert Schöler, Jared L. Sterneckert · 2014 · Trends in Pharmacological Sciences
APP Processing in Human Pluripotent Stem Cell-Derived Neurons Is Resistant to NSAID-Based γ-Secretase Modulation
Jérôme Mertens, Kathrin Stüber, Patrick Wunderlich, Julia Ladewig, Jaideep Kesavan, Rik R. Vandenberghe, Mathieu Vandenbulcke, Philip Van Damme, Jochen Walter, Oliver Brüstle et al. · 2013 · Stem Cell Reports
Human induced pluripotent stem cells—from mechanisms to clinical applications
Katharina Drews, Justyna Józefczuk, Alessandro Prigione, James Adjaye · 2012 · Journal of Molecular Medicine
Concise Review: Can Stem Cells be Used to Treat or Model Alzheimer's Disease?
Wesley W. Chen, Mathew M. Blurton-Jones · 2012 · Stem Cells
Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders
Qiang, Liang, Fujita, Ryousuke, Abeliovich, Asa · 2013 · Neuron
Reverse electron transfer is activated during aging and contributes to aging and age‐related disease
Suman Rimal, Ishaq Tantray, Yu Li, Tejinder Pal Khaket, Yanping Li, Sunil Bhurtel, Wen Li, Cici Zeng, Bingwei Lu · 2023 · EMBO Reports
Characterizing Human Ion Channels in Induced Pluripotent Stem Cell–Derived Neurons
Alison Haythornthwaite, Sonja Stoelzle, Alexander Hasler, Andrea Kiss, Johannes Mosbacher, Michael George, Andrea Brüggemann, Niels Fertig · 2012 · SLAS DISCOVERY
Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery
Stefania Paola Corti, Irene Faravelli, Marina Cardano, Luciano Conti · 2015 · Expert Opinion on Drug Discovery
iPSC technology-Powerful hand for disease modeling and therapeutic screen
Changsung Kim · 2015 · BMB Reports
Tauopathy-Associated PERK Alleles are Functional Hypomorphs that Increase Neuronal Vulnerability to ER Stress
Shauna H. Yuan, Nobuhiko Hiramatsu, Qing Liu, Xuehan Sun, David Lenh, Priscilla Chan, Karen Chiang, Edward H. Koo, Aimee Kao, Irene Litvan et al. · 2018 · Human Molecular Genetics
Enhanced Neuronal Activity and Asynchronous Calcium Transients Revealed in a 3D Organoid Model of Alzheimer’s Disease
Juan Yin, Antonius M.J. VanDongen · 2020 · ACS Biomaterials Science & Engineering
Stem Cells on the Brain: Modeling Neurodevelopmental and Neurodegenerative Diseases Using Human Induced Pluripotent Stem Cells
Priya Srikanth, Tracy L. Young‐Pearse · 2014 · Journal of Neurogenetics